DA
CELG

Dillon & Associates’s Celgene Corp CELG Stock Holding History

Dillon & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,659
Closed -$263K – 70
2019
Q3 		$263K Sell
2,659
-10,534
-80% -$1M 0.08% 61
2019
Q2 		$1.21M Sell
13,193
-47,693
-78% -$4.53M 0.38% 42
2019
Q1 		$5.72M Sell
60,886
-3,450
-5% -$302K 1.86% 23
2018
Q4 		$4.12M Sell
64,336
-8,220
-11% -$607K 1.57% 27
2018
Q3 		$6.46M Buy
72,556
+1,065
+1% +$94.1K 2.14% 22
2018
Q2 		$5.65M Buy
71,491
+9,835
+16% +$817K 2.09% 21
2018
Q1 		$5.49M Buy
61,656
+9,612
+18% +$923K 2.12% 20
2017
Q4 		$5.41M Buy
52,044
+4,321
+9% +$488K 2.04% 20
2017
Q3 		$6.97M Buy
47,723
+850
+2% +$116K 2.75% 13
2017
Q2 		$6.09M Buy
46,873
+2,095
+5% +$257K 2.51% 16
2017
Q1 		$5.55M Buy
44,778
+1,188
+3% +$142K 2.36% 16
2016
Q4 		$5.06M Buy
43,590
+595
+1% +$66.3K 2.3% 18
2016
Q3 		$4.51M Buy
42,995
+1,040
+2% +$113K 2.08% 20
2016
Q2 		$4.15M Buy
41,955
+1,195
+3% +$124K 1.91% 23
2016
Q1 		$4.08M Buy
40,760
+2,240
+6% +$231K 1.89% 22
2015
Q4 		$4.62M Buy
38,520
+780
+2% +$90.2K 2.23% 19
2015
Q3 		$4.08M Buy
37,740
+1,350
+4% +$168K 2.04% 22
2015
Q2 		$4.22M Buy
36,390
+1,387
+4% +$159K 2.06% 22
2015
Q1 		$4.03M Buy
35,003
+1,408
+4% +$168K 1.93% 22
2014
Q4 		$3.76M Buy
33,595
+1,875
+6% +$198K 1.83% 23
2014
Q3 		$3.01M Buy
31,720
+965
+3% +$87.1K 1.54% 26
2014
Q2 		$2.64M Buy
30,755
+4,675
+18% +$356K 1.36% 27
2014
Q1 		$1.83M Buy
26,080
+2,610
+11% +$207K 0.98% 30
2013
Q4 		$1.98M Buy
23,470
+370
+2% +$29.3K 1.07% 29
2013
Q3 		$1.79M Buy
23,100
+470
+2% +$32.9K 1% 32
2013
Q2 		$1.32M Buy
+22,630
New +$1.36M 0.85% 38

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Dillon & Associates's CELG Position: Q4 2019 in Review

Dillon & Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,659 shares — an estimated $263K sold.

Dillon & Associates first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.97M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Dillon & Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Dillon & Associates sold 2,659 Celgene Corp shares in Q4 2019, an estimated $263K.
  • Dillon & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Dillon & Associates's Celgene Corp position peaked at $6.97M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Dillon & Associates's 13F filing for Q4 2019, filed 3 Feb 2020.